Konstantinos Stavropoulos Selected Research

Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)

1/2018

Role of PCSK9 Inhibitors in High Risk Patients with Dyslipidemia: Focus on Familial Hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Stavropoulos Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
9	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2017
9	Hypertension (High Blood Pressure) 01/2020 - 04/2016
8	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
7	Heart Failure 08/2022 - 01/2017
7	Body Weight (Weight, Body) 12/2019 - 01/2017
5	Stroke (Strokes) 01/2019 - 07/2016
4	Hyperaldosteronism (Conn Syndrome) 01/2022 - 01/2018
4	Albuminuria 01/2021 - 01/2017
4	Dyslipidemias (Dyslipidemia) 04/2018 - 01/2017
3	Inflammation (Inflammations) 03/2024 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 01/2018
2	COVID-19 01/2022 - 10/2020
2	Diabetes Mellitus 01/2022 - 01/2017
2	Chronic Renal Insufficiency 01/2021 - 01/2018
2	Infections 10/2020 - 01/2018
2	Fibrosis (Cirrhosis) 04/2018 - 01/2018
2	Fatty Liver 04/2018 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 04/2018 - 01/2018
1	Overweight 12/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Critical Illness (Critically Ill) 10/2020
1	Disease Progression 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 07/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Erectile Dysfunction 01/2020
1	Insulin Resistance 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 12/2019
1	Hepatitis 04/2018
1	Liver Diseases (Liver Disease) 04/2018
1	Weight Gain 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Arteritis 01/2018
1	Hyperglycemia 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Myocardial Infarction 01/2018
1	Obesity 01/2018
1	Alcoholic Fatty Liver 01/2018
1	Thrombosis (Thrombus) 01/2018

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 01/2017
11	SodiumIBA 08/2022 - 01/2017
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2018
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2017
5	Mineralocorticoid Receptor AntagonistsIBA 08/2022 - 01/2017
5	Sodium-Glucose Transport ProteinsIBA 10/2019 - 01/2018
5	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 01/2017
4	SymportersIBA 08/2022 - 01/2017
4	Insulin (Novolin)FDA Link 07/2020 - 01/2018
4	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2017
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2019 - 01/2018
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
3	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2022 - 01/2017
3	Pioglitazone (Actos)FDA Link 01/2019 - 01/2018
3	oxidized low density lipoproteinIBA 03/2018 - 01/2018
3	LDL CholesterolIBA 03/2018 - 01/2018
3	Atorvastatin (Lipitor)FDA Link 01/2018 - 01/2018
2	HDL CholesterolIBA 04/2023 - 03/2018
2	EnzymesIBA 01/2018 - 01/2018
2	Vitamin E FDA LinkGeneric 01/2018 - 01/2018
2	AldosteroneIBA 01/2018 - 01/2018
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 04/2016
2	empagliflozinIBA 11/2017 - 01/2017
2	CanagliflozinIBA 11/2017 - 10/2016
1	CytokinesIBA 03/2024
1	Monoclonal AntibodiesIBA 03/2024
1	MicroRNAs (MicroRNA)IBA 03/2024
1	tirzepatideIBA 12/2023
1	Ranolazine FDA Link 01/2022
1	Carrier Proteins (Binding Protein)IBA 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	IronIBA 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020
1	PTX3 proteinIBA 01/2019
1	ThiazolidinedionesIBA 01/2019
1	LeptinIBA 01/2019
1	Ezetimibe (Zetia)FDA Link 01/2019
1	MineralocorticoidsIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 03/2018
1	Fibric Acids (Fibrates)IBA 03/2018
1	PotassiumIBA 01/2018
1	Trinitrotoluene (TNT)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Drug CombinationsIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2020 - 11/2017
2	Adrenalectomy 01/2022 - 01/2018
2	Denervation 01/2020 - 11/2019
2	Glycemic Control 12/2019 - 01/2018
1	Secondary Prevention 01/2021
1	Catheters 01/2020